Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06389916 · ClinicalTrials.gov registry record · NA
Euclid Phoenix Lens Design Trial
A NA study of Myopia and Cornea, sponsored by Euclid Systems Corporation.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 5
- Study locations
NCT06389916 is a NA study of Myopia and Cornea that is active but no longer recruiting, run by Euclid Systems Corporation. The registered enrollment target is 30 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (89% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06389916, a NA study of Myopia and Cornea, is active but no longer recruiting, sponsored by Euclid Systems Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 5
- Study locations
Study Summary
The "first fit" success rate of the current Euclid orthokeratology "MAX" lens design will be compared to that of the new Euclid orthokeratology MAX "Phoenix" lens design in 30 children.
Interventions
- DEVICE Euclid orthokeratology MAX (current design)
- DEVICE Euclid orthokeratology MAX Phoenix (new design)
Study Locations (5)
California
- Insight Vision Center Optometry - Costa Mesa
Florida
- Dau Family Eye Care - Saint Johns
Minnesota
- Cornea and Contact Lens Institute of Minnesota - Edina
New Jersey
- Somerset Eye Care - North Brunswick
Virginia
- Treehouse Eyes - Tysons Corner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2024-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06389916
The ClinicalTrials.gov registry entry for NCT06389916 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (89% lower). The listed sponsor is Euclid Systems Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Euclid orthokeratology MAX (current design) is the first listed.
NCT06389916 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06389916 about?
NCT06389916 is a clinical study titled "Euclid Phoenix Lens Design Trial". The "first fit" success rate of the current Euclid orthokeratology "MAX" lens design will be compared to that of the new Euclid orthokeratology MAX "Phoenix" lens design in 30 children.
What is the current status of trial NCT06389916?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-11-01. Estimated completion is 2024-04.
What conditions does trial NCT06389916 study?
This clinical trial studies the following conditions: Myopia, Cornea.
What interventions are being tested in trial NCT06389916?
The interventions under investigation include: Euclid orthokeratology MAX (current design) (DEVICE), Euclid orthokeratology MAX Phoenix (new design) (DEVICE).
Who is sponsoring clinical trial NCT06389916?
This trial is sponsored by Euclid Systems Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06389916 being conducted?
This trial has 5 study locations across California, Florida, Minnesota, New Jersey, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.